Mitochondrial glutaminase enhances extracellular glutamate production in HIV-1-infected macrophages: Linkage to HIV-1 associated dementia

Jianxing Zhao, Alicia L. Lopez, David Erichsen, Shelley Herek, Robin L. Cotter, Norman P. Curthoys, Jialin C Zheng

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Dysfunction in mononuclear phagocyte (MP, macrophages and microglia) immunity is thought to play a significant role in the pathogenesis of HIV-1 associated dementia (HAD). In particular, elevated extracellular concentrations of the excitatory neurotransmitter glutamate, produced by MP as a consequence of viral infection and immune activation, can induce neuronal injury. To determine the mechanism by which MP-mediated neuronal injury occurs, the concentration and rates of production of extracellular glutamate were measured in human monocyte-derived macrophage (MDM) supernatants by reverse phase high-performance liquid chromatography (RP-HPLC). Measurements were taken of supernatants from MDM infected with multiple HIV-1 strains including ADA and DJV (macrophage tropic, M-tropic), and 89.6 (dual tropic). High levels of glutamate were produced by MDM infected with M-tropic viruses. AZT, an inhibitor of HIV-1 replication, inhibited glutamate generation, demonstrating a linkage between HIV-1 infection and enhanced glutamate production. In our culture system, glutamate production was dependent upon the presence of glutamine and was inhibited by 6-diazo-5-oxo-L-norleucine, a glutaminase inhibitor. Supernatants collected from HIV-1-infected MP generated more glutamate following glutamine addition than supernatants isolated from uninfected MP. These findings implicate the involvement of a glutamate-generating enzyme, such as phosphate-activated mitochondrial glutaminase (PMG) in MP-mediated glutamate production.

Original languageEnglish (US)
Pages (from-to)169-180
Number of pages12
JournalJournal of Neurochemistry
Volume88
Issue number1
StatePublished - Jan 1 2004

Fingerprint

Glutaminase
Macrophages
Dementia
HIV-1
Glutamic Acid
Tropics
Glutamine
Diazooxonorleucine
Wounds and Injuries
High performance liquid chromatography
Microglia
Virus Diseases
Reverse-Phase Chromatography
Phagocytes
Viruses
HIV Infections
Neurotransmitter Agents
Immunity
Chemical activation
Phosphates

Keywords

  • Dementia
  • Glutamate
  • Glutaminase
  • HIV-1
  • Macrophage
  • Neurotoxicity

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Mitochondrial glutaminase enhances extracellular glutamate production in HIV-1-infected macrophages : Linkage to HIV-1 associated dementia. / Zhao, Jianxing; Lopez, Alicia L.; Erichsen, David; Herek, Shelley; Cotter, Robin L.; Curthoys, Norman P.; Zheng, Jialin C.

In: Journal of Neurochemistry, Vol. 88, No. 1, 01.01.2004, p. 169-180.

Research output: Contribution to journalArticle

Zhao, Jianxing ; Lopez, Alicia L. ; Erichsen, David ; Herek, Shelley ; Cotter, Robin L. ; Curthoys, Norman P. ; Zheng, Jialin C. / Mitochondrial glutaminase enhances extracellular glutamate production in HIV-1-infected macrophages : Linkage to HIV-1 associated dementia. In: Journal of Neurochemistry. 2004 ; Vol. 88, No. 1. pp. 169-180.
@article{5e9f216cb06e45b687213e92c2d1194c,
title = "Mitochondrial glutaminase enhances extracellular glutamate production in HIV-1-infected macrophages: Linkage to HIV-1 associated dementia",
abstract = "Dysfunction in mononuclear phagocyte (MP, macrophages and microglia) immunity is thought to play a significant role in the pathogenesis of HIV-1 associated dementia (HAD). In particular, elevated extracellular concentrations of the excitatory neurotransmitter glutamate, produced by MP as a consequence of viral infection and immune activation, can induce neuronal injury. To determine the mechanism by which MP-mediated neuronal injury occurs, the concentration and rates of production of extracellular glutamate were measured in human monocyte-derived macrophage (MDM) supernatants by reverse phase high-performance liquid chromatography (RP-HPLC). Measurements were taken of supernatants from MDM infected with multiple HIV-1 strains including ADA and DJV (macrophage tropic, M-tropic), and 89.6 (dual tropic). High levels of glutamate were produced by MDM infected with M-tropic viruses. AZT, an inhibitor of HIV-1 replication, inhibited glutamate generation, demonstrating a linkage between HIV-1 infection and enhanced glutamate production. In our culture system, glutamate production was dependent upon the presence of glutamine and was inhibited by 6-diazo-5-oxo-L-norleucine, a glutaminase inhibitor. Supernatants collected from HIV-1-infected MP generated more glutamate following glutamine addition than supernatants isolated from uninfected MP. These findings implicate the involvement of a glutamate-generating enzyme, such as phosphate-activated mitochondrial glutaminase (PMG) in MP-mediated glutamate production.",
keywords = "Dementia, Glutamate, Glutaminase, HIV-1, Macrophage, Neurotoxicity",
author = "Jianxing Zhao and Lopez, {Alicia L.} and David Erichsen and Shelley Herek and Cotter, {Robin L.} and Curthoys, {Norman P.} and Zheng, {Jialin C}",
year = "2004",
month = "1",
day = "1",
language = "English (US)",
volume = "88",
pages = "169--180",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Mitochondrial glutaminase enhances extracellular glutamate production in HIV-1-infected macrophages

T2 - Linkage to HIV-1 associated dementia

AU - Zhao, Jianxing

AU - Lopez, Alicia L.

AU - Erichsen, David

AU - Herek, Shelley

AU - Cotter, Robin L.

AU - Curthoys, Norman P.

AU - Zheng, Jialin C

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Dysfunction in mononuclear phagocyte (MP, macrophages and microglia) immunity is thought to play a significant role in the pathogenesis of HIV-1 associated dementia (HAD). In particular, elevated extracellular concentrations of the excitatory neurotransmitter glutamate, produced by MP as a consequence of viral infection and immune activation, can induce neuronal injury. To determine the mechanism by which MP-mediated neuronal injury occurs, the concentration and rates of production of extracellular glutamate were measured in human monocyte-derived macrophage (MDM) supernatants by reverse phase high-performance liquid chromatography (RP-HPLC). Measurements were taken of supernatants from MDM infected with multiple HIV-1 strains including ADA and DJV (macrophage tropic, M-tropic), and 89.6 (dual tropic). High levels of glutamate were produced by MDM infected with M-tropic viruses. AZT, an inhibitor of HIV-1 replication, inhibited glutamate generation, demonstrating a linkage between HIV-1 infection and enhanced glutamate production. In our culture system, glutamate production was dependent upon the presence of glutamine and was inhibited by 6-diazo-5-oxo-L-norleucine, a glutaminase inhibitor. Supernatants collected from HIV-1-infected MP generated more glutamate following glutamine addition than supernatants isolated from uninfected MP. These findings implicate the involvement of a glutamate-generating enzyme, such as phosphate-activated mitochondrial glutaminase (PMG) in MP-mediated glutamate production.

AB - Dysfunction in mononuclear phagocyte (MP, macrophages and microglia) immunity is thought to play a significant role in the pathogenesis of HIV-1 associated dementia (HAD). In particular, elevated extracellular concentrations of the excitatory neurotransmitter glutamate, produced by MP as a consequence of viral infection and immune activation, can induce neuronal injury. To determine the mechanism by which MP-mediated neuronal injury occurs, the concentration and rates of production of extracellular glutamate were measured in human monocyte-derived macrophage (MDM) supernatants by reverse phase high-performance liquid chromatography (RP-HPLC). Measurements were taken of supernatants from MDM infected with multiple HIV-1 strains including ADA and DJV (macrophage tropic, M-tropic), and 89.6 (dual tropic). High levels of glutamate were produced by MDM infected with M-tropic viruses. AZT, an inhibitor of HIV-1 replication, inhibited glutamate generation, demonstrating a linkage between HIV-1 infection and enhanced glutamate production. In our culture system, glutamate production was dependent upon the presence of glutamine and was inhibited by 6-diazo-5-oxo-L-norleucine, a glutaminase inhibitor. Supernatants collected from HIV-1-infected MP generated more glutamate following glutamine addition than supernatants isolated from uninfected MP. These findings implicate the involvement of a glutamate-generating enzyme, such as phosphate-activated mitochondrial glutaminase (PMG) in MP-mediated glutamate production.

KW - Dementia

KW - Glutamate

KW - Glutaminase

KW - HIV-1

KW - Macrophage

KW - Neurotoxicity

UR - http://www.scopus.com/inward/record.url?scp=0346102601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346102601&partnerID=8YFLogxK

M3 - Article

C2 - 14675161

AN - SCOPUS:0346102601

VL - 88

SP - 169

EP - 180

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 1

ER -